Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Hemoperfusion Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Hemoperfusion Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-03-28

Pages: 130 Pages

Report ld: 4687624

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hemoperfusion Market Size(US$)

CAGR 2025-2031

18.1%

Market Size,2031

USD 2,199

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 811 million

Market Forecast in 2031(Value)

US$ 2,199 million

CAGR

18.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Hemoperfusion was estimated to be worth US$ 697 million and is forecast to reach approximately US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.

Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.

The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemoperfusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemoperfusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company

Jafron Biomedical

Baxter (Gambro)

Asahi-Kasei

Biosun Medical

Kaneka

Toray Medical

Cytosorbents

Aier

Zibo Kangbei

Segment by Type

Activated Carbon Adsorption

Resin Adsorption

Segment by Application

Hepatic Encephalopathy

Certain Autoimmune Diseases

Drug Overdose

Specific Intoxications

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Hemoperfusion in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemoperfusion sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Hemoperfusion Product Introduction

1.2 Market by Type

1.2.1 Global Hemoperfusion Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Activated Carbon Adsorption

1.2.3 Resin Adsorption

1.3 Market by Application

1.3.1 Global Hemoperfusion Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Hepatic Encephalopathy

1.3.3 Certain Autoimmune Diseases

1.3.4 Drug Overdose

1.3.5 Specific Intoxications

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hemoperfusion Market Size Estimates and Forecasts

2.1.1 Global Hemoperfusion Revenue 2020-2031

2.1.2 Global Hemoperfusion Sales 2020-2031

2.2 Hemoperfusion Market Size by Region: 2024 Versus 2031

2.3 Hemoperfusion Sales by Region (2020-2031)

2.3.1 Global Hemoperfusion Sales by Region: 2020-2025

2.3.2 Global Hemoperfusion Sales Forecast by Region (2026-2031)

2.3.3 Global Hemoperfusion Sales Market Share by Region (2020-2031)

2.4 Hemoperfusion Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Hemoperfusion Revenue by Region: 2020-2025

2.4.2 Global Hemoperfusion Revenue Forecast by Region (2026-2031)

2.4.3 Global Hemoperfusion Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Hemoperfusion Sales by Type (2020-2031)

3.1.1.1 Global Hemoperfusion Sales Volume by Type (2020-2031)

3.1.1.2 Global Hemoperfusion Sales Market Share by Type (2020-2031)

3.1.2 Global Hemoperfusion Revenue by Type (2020-2031)

3.1.2.1 Global Hemoperfusion Revenue by Type (2020-2031)

3.1.2.2 Global Hemoperfusion Revenue Market Share by Type (2020-2031)

3.1.3 Hemoperfusion Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Hemoperfusion Sales by Application (2020-2031)

3.2.1.1 Global Hemoperfusion Sales Volume by Application (2020-2031)

3.2.1.2 Global Hemoperfusion Sales Market Share by Application (2020-2031)

3.2.2 Global Hemoperfusion Revenue by Application (2020-2031)

3.2.2.1 Global Hemoperfusion Revenue by Application (2020-2031)

3.2.2.2 Global Hemoperfusion Revenue Market Share by Application (2020-2031)

3.2.3 Hemoperfusion Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Activated Carbon Adsorption of Hemoperfusion Revenue Market Share by Application

3.3.2 Resin Adsorption of Hemoperfusion Revenue Market Share by Application

4 Global Hemoperfusion by Manufacturers

4.1 Global Top Hemoperfusion Manufacturers by Sales (2020-2025)

4.1.1 Global Hemoperfusion Sales by Manufacturer (2020-2025)

4.1.2 Global Hemoperfusion Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Hemoperfusion Manufacturers by Revenue (2020-2025)

4.2.1 Global Hemoperfusion Revenue by Manufacturer (2020-2025)

4.2.2 Global Hemoperfusion Revenue Share by Manufacturer (2020-2025)

4.3 Global Hemoperfusion Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Hemoperfusion Manufacturers Covered: Ranking by Revenue

4.4.2 Global Hemoperfusion Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Hemoperfusion Manufacturing Base Distribution, Product Type

4.5.1 Hemoperfusion Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Hemoperfusion Market

4.5.3 Manufacturers Hemoperfusion Product Type and Application

4.5.4 Activated Carbon Adsorption Market Sales of Hemoperfusion by Manufacturer

4.5.5 Resin Adsorption Market Sales of Hemoperfusion by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Jafron Biomedical

5.1.1 Jafron Biomedical Company Information

5.1.2 Jafron Biomedical Description, Business Overview

5.1.3 Jafron Biomedical Hemoperfusion Products Offered

5.1.4 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Jafron Biomedical Hemoperfusion Sales by Product in 2024

5.1.6 Jafron Biomedical Hemoperfusion Sales by Application in 2024

5.1.7 Jafron Biomedical Hemoperfusion Sales by Geographic Area in 2024

5.1.8 Jafron Biomedical Recent Developments

5.2 Baxter (Gambro)

5.2.1 Baxter (Gambro) Company Information

5.2.2 Baxter (Gambro) Description, Business Overview

5.2.3 Baxter (Gambro) Hemoperfusion Products Offered

5.2.4 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Baxter (Gambro) Hemoperfusion Sales by Product in 2024

5.2.6 Baxter (Gambro) Hemoperfusion Sales by Application in 2024

5.2.7 Baxter (Gambro) Hemoperfusion Sales by Geographic Area in 2024

5.2.8 Baxter (Gambro) Recent Developments

5.3 Asahi-Kasei

5.3.1 Asahi-Kasei Company Information

5.3.2 Asahi-Kasei Description, Business Overview

5.3.3 Asahi-Kasei Hemoperfusion Products Offered

5.3.4 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Asahi-Kasei Hemoperfusion Sales by Product in 2024

5.3.6 Asahi-Kasei Hemoperfusion Sales by Application in 2024

5.3.7 Asahi-Kasei Hemoperfusion Sales by Geographic Area in 2024

5.3.8 Asahi-Kasei Recent Developments

5.4 Biosun Medical

5.4.1 Biosun Medical Company Information

5.4.2 Biosun Medical Description, Business Overview

5.4.3 Biosun Medical Hemoperfusion Products Offered

5.4.4 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Biosun Medical Hemoperfusion Sales by Product in 2024

5.4.6 Biosun Medical Hemoperfusion Sales by Application in 2024

5.4.7 Biosun Medical Hemoperfusion Sales by Geographic Area in 2024

5.4.8 Biosun Medical Recent Developments

5.5 Kaneka

5.5.1 Kaneka Company Information

5.5.2 Kaneka Description, Business Overview

5.5.3 Kaneka Hemoperfusion Products Offered

5.5.4 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Kaneka Hemoperfusion Sales by Product in 2024

5.5.6 Kaneka Hemoperfusion Sales by Application in 2024

5.5.7 Kaneka Hemoperfusion Sales by Geographic Area in 2024

5.5.8 Kaneka Recent Developments

5.6 Toray Medical

5.6.1 Toray Medical Company Information

5.6.2 Toray Medical Description, Business Overview

5.6.3 Toray Medical Hemoperfusion Products Offered

5.6.4 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Toray Medical Hemoperfusion Sales by Product in 2024

5.6.6 Toray Medical Hemoperfusion Sales by Application in 2024

5.6.7 Toray Medical Hemoperfusion Sales by Geographic Area in 2024

5.6.8 Toray Medical Recent Developments

5.7 Cytosorbents

5.7.1 Cytosorbents Company Information

5.7.2 Cytosorbents Description, Business Overview

5.7.3 Cytosorbents Hemoperfusion Products Offered

5.7.4 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Cytosorbents Hemoperfusion Sales by Product in 2024

5.7.6 Cytosorbents Hemoperfusion Sales by Application in 2024

5.7.7 Cytosorbents Hemoperfusion Sales by Geographic Area in 2024

5.7.8 Cytosorbents Recent Developments

5.8 Aier

5.8.1 Aier Company Information

5.8.2 Aier Description, Business Overview

5.8.3 Aier Hemoperfusion Products Offered

5.8.4 Aier Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Aier Hemoperfusion Sales by Product in 2024

5.8.6 Aier Hemoperfusion Sales by Application in 2024

5.8.7 Aier Hemoperfusion Sales by Geographic Area in 2024

5.8.8 Aier Recent Developments

5.9 Zibo Kangbei

5.9.1 Zibo Kangbei Company Information

5.9.2 Zibo Kangbei Description, Business Overview

5.9.3 Zibo Kangbei Hemoperfusion Products Offered

5.9.4 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Zibo Kangbei Hemoperfusion Sales by Product in 2024

5.9.6 Zibo Kangbei Hemoperfusion Sales by Application in 2024

5.9.7 Zibo Kangbei Hemoperfusion Sales by Geographic Area in 2024

5.9.8 Zibo Kangbei Recent Developments

6 North America

6.1 North America Hemoperfusion Market Size YoY Growth 2020-2031

6.2 North America Hemoperfusion Market Facts & Figures by Country

6.2.1 North America Hemoperfusion Sales by Country (2020-2031)

6.2.2 North America Hemoperfusion Revenue by Country (2020-2031)

6.3 North America Hemoperfusion Sales by Type (2020-2025)

6.4 North America Hemoperfusion Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Hemoperfusion Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Hemoperfusion Market Facts & Figures by Region

7.2.1 Asia-Pacific Hemoperfusion Sales by Region (2020-2031)

7.2.2 Asia-Pacific Hemoperfusion Revenue by Region (2020-2031)

7.3 Asia-Pacific Hemoperfusion Sales by Type (2020-2025)

7.4 Asia-Pacific Hemoperfusion Sales by Application (2020-2025)

8 Europe

8.1 Europe Hemoperfusion Market Size YoY Growth 2020-2031

8.2 Europe Hemoperfusion Market Facts & Figures by Country

8.2.1 Europe Hemoperfusion Sales by Country (2020-2031)

8.2.2 Europe Hemoperfusion Revenue by Country (2020-2031)

8.3 Europe Hemoperfusion Sales by Type (2020-2025)

8.4 Europe Hemoperfusion Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Hemoperfusion Market Size YoY Growth 2020-2031

9.2 Latin America Hemoperfusion Market Facts & Figures by Country

9.2.1 Latin America Hemoperfusion Sales by Country (2020-2031)

9.2.2 Latin America Hemoperfusion Revenue by Country (2020-2031)

9.3 Latin America Hemoperfusion Sales by Type (2020-2025)

9.4 Latin America Hemoperfusion Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Hemoperfusion Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Hemoperfusion Market Facts & Figures by Country

10.2.1 Middle East and Africa Hemoperfusion Sales by Country (2020-2031)

10.2.2 Middle East and Africa Hemoperfusion Revenue by Country (2020-2031)

10.3 Middle East and Africa Hemoperfusion Sales by Type (2020-2025)

10.4 Middle East and Africa Hemoperfusion Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Hemoperfusion Supply Chain Analysis

11.2 Hemoperfusion Key Raw Materials and Upstream Suppliers

11.3 Hemoperfusion Clients Analysis

11.4 Hemoperfusion Sales Channel and Sales Model Analysis

11.4.1 Hemoperfusion Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Hemoperfusion Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Hemoperfusion Distributors

12 Hemoperfusion Market Dynamics

12.1 Hemoperfusion Industry Trends

12.2 Hemoperfusion Market Drivers

12.3 Hemoperfusion Market Challenges

12.4 Hemoperfusion Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Hemoperfusion Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Hemoperfusion Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Hemoperfusion Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Hemoperfusion Sales by Region (2020-2025) & (K Units)

Table 5. Global Hemoperfusion Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Hemoperfusion Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Hemoperfusion Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Hemoperfusion Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Hemoperfusion Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Hemoperfusion Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Hemoperfusion Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Hemoperfusion Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Hemoperfusion Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Hemoperfusion Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Hemoperfusion Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Hemoperfusion Sales Share by Manufacturer (2020-2025)

Table 18. Hemoperfusion Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Hemoperfusion Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Hemoperfusion Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Hemoperfusion Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Hemoperfusion Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2024)

Table 24. Hemoperfusion Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Hemoperfusion Market

Table 26. Manufacturers Hemoperfusion Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Jafron Biomedical Company Information

Table 29. Jafron Biomedical Description and Business Overview

Table 30. Jafron Biomedical Hemoperfusion Product

Table 31. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Jafron Biomedical Sales Proportion of Hemoperfusion by Product in 2024

Table 33. Jafron Biomedical Sales Proportion of Hemoperfusion by Application in 2024

Table 34. Jafron Biomedical Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 35. Jafron Biomedical Recent Developments

Table 36. Baxter (Gambro) Company Information

Table 37. Baxter (Gambro) Description and Business Overview

Table 38. Baxter (Gambro) Hemoperfusion Product

Table 39. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. Baxter (Gambro) Sales Proportion of Hemoperfusion by Product in 2024

Table 41. Baxter (Gambro) Sales Proportion of Hemoperfusion by Application in 2024

Table 42. Baxter (Gambro) Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 43. Baxter (Gambro) Recent Developments

Table 44. Asahi-Kasei Company Information

Table 45. Asahi-Kasei Description and Business Overview

Table 46. Asahi-Kasei Hemoperfusion Product

Table 47. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Asahi-Kasei Sales Proportion of Hemoperfusion by Product in 2024

Table 49. Asahi-Kasei Sales Proportion of Hemoperfusion by Application in 2024

Table 50. Asahi-Kasei Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 51. Asahi-Kasei Recent Developments

Table 52. Biosun Medical Company Information

Table 53. Biosun Medical Description and Business Overview

Table 54. Biosun Medical Hemoperfusion Product

Table 55. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Biosun Medical Sales Proportion of Hemoperfusion by Product in 2024

Table 57. Biosun Medical Sales Proportion of Hemoperfusion by Application in 2024

Table 58. Biosun Medical Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 59. Biosun Medical Recent Developments

Table 60. Kaneka Company Information

Table 61. Kaneka Description and Business Overview

Table 62. Kaneka Hemoperfusion Product

Table 63. Kaneka Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Kaneka Sales Proportion of Hemoperfusion by Product in 2024

Table 65. Kaneka Sales Proportion of Hemoperfusion by Application in 2024

Table 66. Kaneka Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 67. Kaneka Recent Developments

Table 68. Toray Medical Company Information

Table 69. Toray Medical Description and Business Overview

Table 70. Toray Medical Hemoperfusion Product

Table 71. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. Toray Medical Sales Proportion of Hemoperfusion by Product in 2024

Table 73. Toray Medical Sales Proportion of Hemoperfusion by Application in 2024

Table 74. Toray Medical Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 75. Toray Medical Recent Developments

Table 76. Cytosorbents Company Information

Table 77. Cytosorbents Description and Business Overview

Table 78. Cytosorbents Hemoperfusion Product

Table 79. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Cytosorbents Sales Proportion of Hemoperfusion by Product in 2024

Table 81. Cytosorbents Sales Proportion of Hemoperfusion by Application in 2024

Table 82. Cytosorbents Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 83. Cytosorbents Recent Developments

Table 84. Aier Company Information

Table 85. Aier Description and Business Overview

Table 86. Aier Hemoperfusion Product

Table 87. Aier Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Aier Sales Proportion of Hemoperfusion by Product in 2024

Table 89. Aier Sales Proportion of Hemoperfusion by Application in 2024

Table 90. Aier Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 91. Aier Recent Developments

Table 92. Zibo Kangbei Company Information

Table 93. Zibo Kangbei Description and Business Overview

Table 94. Zibo Kangbei Hemoperfusion Product

Table 95. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 96. Zibo Kangbei Sales Proportion of Hemoperfusion by Product in 2024

Table 97. Zibo Kangbei Sales Proportion of Hemoperfusion by Application in 2024

Table 98. Zibo Kangbei Sales Proportion of Hemoperfusion by Geographic Area in 2024

Table 99. Zibo Kangbei Recent Developments

Table 100. North America Hemoperfusion Sales by Country (2020-2025) & (K Units)

Table 101. North America Hemoperfusion Sales by Country (2026-2031) & (K Units)

Table 102. North America Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)

Table 103. North America Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)

Table 104. North America Hemoperfusion Sales by Type (2020-2025) & (K Units)

Table 105. North America Hemoperfusion Sales by Application (2020-2025) & (K Units)

Table 106. Asia-Pacific Hemoperfusion Sales by Region (2020-2025) & (K Units)

Table 107. Asia-Pacific Hemoperfusion Sales by Region (2026-2031) & (K Units)

Table 108. Asia-Pacific Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)

Table 109. Asia-Pacific Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)

Table 110. Asia-Pacific Hemoperfusion Sales by Type (2020-2025) & (K Units)

Table 111. Asia-Pacific Hemoperfusion Sales by Application (2020-2025) & (K Units)

Table 112. Europe Hemoperfusion Sales by Country (2020-2025) & (K Units)

Table 113. Europe Hemoperfusion Sales by Country (2026-2031) & (K Units)

Table 114. Europe Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)

Table 115. Europe Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)

Table 116. Europe Hemoperfusion Sales by Type (2020-2025) & (K Units)

Table 117. Europe Hemoperfusion Sales by Application (2020-2025) & (K Units)

Table 118. Latin America Hemoperfusion Sales by Country (2020-2025) & (K Units)

Table 119. Latin America Hemoperfusion Sales by Country (2026-2031) & (K Units)

Table 120. Latin America Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)

Table 121. Latin America Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)

Table 122. Latin America Hemoperfusion Sales by Type (2020-2025) & (K Units)

Table 123. Latin America Hemoperfusion Sales by Application (2020-2025) & (K Units)

Table 124. Middle East and Africa Hemoperfusion Sales by Country (2020-2025) & (K Units)

Table 125. Middle East and Africa Hemoperfusion Sales by Country (2026-2031) & (K Units)

Table 126. Middle East and Africa Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)

Table 127. Middle East and Africa Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)

Table 128. Middle East and Africa Hemoperfusion Sales by Type (2020-2025) & (K Units)

Table 129. Middle East and Africa Hemoperfusion Sales by Application (2020-2025) & (K Units)

Table 130. Hemoperfusion Key Raw Materials, Industry Status and Trend

Table 131. Hemoperfusion Key Raw Materials and Upstream Suppliers

Table 132. Hemoperfusion Clients Status and Trend

Table 133. Hemoperfusion Typical Clients

Table 134. Hemoperfusion Distributors

Table 135. Hemoperfusion Market Trends

Table 136. Hemoperfusion Market Drivers

Table 137. Hemoperfusion Market Challenges

Table 138. Hemoperfusion Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Hemoperfusion Product Picture

Figure 2. Global Hemoperfusion Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Hemoperfusion Sales Market Share by Type in 2024 & 2031

Figure 4. Activated Carbon Adsorption Product Picture

Figure 5. Resin Adsorption Product Picture

Figure 6. Global Hemoperfusion Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Hemoperfusion Sales Market Share by Application in 2024 & 2031

Figure 8. Hepatic Encephalopathy

Figure 9. Certain Autoimmune Diseases

Figure 10. Drug Overdose

Figure 11. Specific Intoxications

Figure 12. Others

Figure 13. Hemoperfusion Report Years Considered

Figure 14. Global Hemoperfusion Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Hemoperfusion Market Size 2020-2031 (US$ Million)

Figure 16. Global Hemoperfusion Sales 2020-2031 (K Units)

Figure 17. Global Hemoperfusion Sales Market Share Forecast by Region (2020-2031)

Figure 18. Global Hemoperfusion Revenue Market Share by Region (2020-2031)

Figure 19. Global Hemoperfusion Sales Market Share Forecast by Type (2020-2031)

Figure 20. Global Hemoperfusion Revenue Market Share Forecast by Type (2020-2031)

Figure 21. Hemoperfusion Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 22. Global Hemoperfusion Sales Market Share Forecast by Application (2020-2031)

Figure 23. Global Hemoperfusion Revenue Market Share Forecast by Application (2020-2031)

Figure 24. Hemoperfusion Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 25. Activated Carbon Adsorption of Hemoperfusion Revenue Market Share by Application, 2024 VS 2031

Figure 26. Resin Adsorption of Hemoperfusion Revenue Market Share by Application, 2024 VS 2031

Figure 27. Global Hemoperfusion Sales Share by Manufacturer in 2024

Figure 28. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. Activated Carbon Adsorption Market Sales Proportion by Manufacturer in 2024

Figure 30. Resin Adsorption Market Sales Proportion by Manufacturer in 2024

Figure 31. North America Hemoperfusion Revenue 2020-2031 (US$ Million)

Figure 32. North America Hemoperfusion Sales Market Share by Type (2020-2025)

Figure 33. North America Hemoperfusion Sales Market Share by Application (2020-2025)

Figure 34. Asia-Pacific Hemoperfusion Revenue 2020-2031 (US$ Million)

Figure 35. Asia-Pacific Hemoperfusion Sales Market Share by Region (2020-2031)

Figure 36. Asia-Pacific Hemoperfusion Revenue Market Share by Region (2020-2031)

Figure 37. Asia-Pacific Hemoperfusion Sales Market Share by Type (2020-2025)

Figure 38. Asia-Pacific Hemoperfusion Sales Market Share by Application (2020-2025)

Figure 39. Europe Hemoperfusion Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Europe Hemoperfusion Sales Market Share by Country (2020-2031)

Figure 41. Europe Hemoperfusion Revenue Market Share by Country (2020-2031)

Figure 42. Europe Hemoperfusion Sales Market Share by Type (2020-2025)

Figure 43. Europe Hemoperfusion Sales Market Share by Application (2020-2025)

Figure 44. Latin America Hemoperfusion Revenue Growth Rate 2020-2031 (US$ Million)

Figure 45. Latin America Hemoperfusion Sales Market Share by Country (2020-2031)

Figure 46. Latin America Hemoperfusion Revenue Market Share by Country (2020-2025)

Figure 47. Latin America Hemoperfusion Sales Market Share by Type (2020-2025)

Figure 48. Latin America Hemoperfusion Sales Market Share by Application (2020-2025)

Figure 49. Middle East and Africa Hemoperfusion Revenue Growth Rate 2020-2031 (US$ Million)

Figure 50. Middle East and Africa Hemoperfusion Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Hemoperfusion Revenue Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Hemoperfusion Sales Market Share by Type (2020-2025)

Figure 53. Middle East and Africa Hemoperfusion Sales Market Share by Application (2020-2025)

Figure 54. Hemoperfusion Supply Chain (Upstream and Downstream Market)

Figure 55. Global Production Market Share of Hemoperfusion Raw Materials by Region in 2024

Figure 56. Hemoperfusion Distribution Channels

Figure 57. Global Hemoperfusion Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 58. Global Hemoperfusion Percentage 2020-2031: Online Sales VS Offline Sales

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Hemoperfusion in 2025? zhanKai

The global market size of Hemoperfusion in 2025 was 811 Million USD.

What was the global market size of Hemoperfusion in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Hemoperfusion market size from 2025 to 2031? shouQi

Which companies rank high in the global Hemoperfusion market? shouQi

Related Reports

Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemoperfusion market size was US$ 478 million in 2025 and is forecast to reach a readjusted size of US$ 814 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 67
USD 4250.00
(Single User License)
Global Hemoperfusion Market Research Report 2026
The global Hemoperfusion market was valued at US$ 478 million in 2025 and is anticipated to reach US$ 814 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 104
USD 2900.00
(Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemoperfusion was estimated to be worth US$ 478 million in 2025 and is projected to reach US$ 814 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 82
USD 3950.00
(Single User License)
Global Hemoperfusion Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 697 million in 2024 to US$ 2199 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 120
USD 4900.00
(Single User License)
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemoperfusion market size was US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 74
USD 4250.00
(Single User License)
Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-07-02
Pages: 84
USD 3950.00
(Single User License)
Global Hemoperfusion Market Insights, Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 811 million in 2025 to US$ 2199 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period.
Published Date: 2025-07-02
Pages: 118
USD 4900.00
(Single User License)
Global Hemoperfusion Market Research Report 2025
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published Date: 2025-07-02
Pages: 72
USD 2900.00
(Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 100
USD 3950.00
(Single User License)
Global Hemoperfusion Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Published Date: 2024-04-17
Pages: 135
USD 5600.00
(Single User License)

Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemoperfusion market size was US$ 478 million in 2025 and is forecast to reach a readjusted size of US$ 814 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 67
USD 4250.00 (Single User License)
Global Hemoperfusion Market Research Report 2026
The global Hemoperfusion market was valued at US$ 478 million in 2025 and is anticipated to reach US$ 814 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 104
USD 2900.00 (Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemoperfusion was estimated to be worth US$ 478 million in 2025 and is projected to reach US$ 814 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 82
USD 3950.00 (Single User License)
Global Hemoperfusion Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 697 million in 2024 to US$ 2199 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 120
USD 4900.00 (Single User License)
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemoperfusion market size was US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 74
USD 4250.00 (Single User License)
Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-07-02
Pages: 84
USD 3950.00 (Single User License)
Global Hemoperfusion Market Insights, Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 811 million in 2025 to US$ 2199 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period.
Published: 2025-07-02
Pages: 118
USD 4900.00 (Single User License)
Global Hemoperfusion Market Research Report 2025
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published: 2025-07-02
Pages: 72
USD 2900.00 (Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 100
USD 3950.00 (Single User License)
Global Hemoperfusion Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Published: 2024-04-17
Pages: 135
USD 5600.00 (Single User License)